Structure Database (LMSD)

LMSD: Structure-based search results

LM_IDCommon NameSystematic NameFormulaMassMain ClassSub Class
LMFA040100084-F4-NeuroP(E)-6-(3,5-dihydroxy-2-((2Z,5Z,8Z)-
undeca-2,5,8-trien-1-yl)cyclopentyl)-4-
hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010011ent-4-F4t-NeuroP(R,E)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010012ent-7-epi-4-F4c-NeuroP(R,E)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010013ent-7-epi-4-F4t-NeuroP(R,E)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010014ent-4-F4c-NeuroP(R,E)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA040100154-epi-4-F4c-NeuroP(R,E)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA040100164,7-diepi-4-F4t-NeuroP(R,E)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA040100174,7-diepi-4-F4c-NeuroP(R,E)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA040100184-epi-4-F4t-NeuroP(R,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010019ent-4-epi-4-Ft-NeuroP(S,E)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010020ent-4,7-diepi-4-Fc-NeuroP(S,E)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010021ent-4,7-diepi-4-Ft-NeuroP(S,E)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010022ent-4-epi-4-Fc-NeuroP(S,E)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA040100234-F4c-NeuroP(S,E)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA040100247-epi-4-F4t-NeuroP(S,E)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA040100257-epi-4-F4c-NeuroP(S,E)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA040100264-F4t-NeuroP(S,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-
((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)
cyclopentyl)-4-hydroxyhex-5-enoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]